Ribomic Inc.

2026/10/12 19:39 Updated
Market Cap: $25.4M (¥4.0B)
Stock Price: $0.45 (¥71)
Exchange Rate: 1 USD = ¥158.23

Notice of Expansion of Clinical Trial Sites (to 6 Facilities) for the Domestic Phase III Clinical Trial of the Osteochondrodysplasia Treatment, Umedaptanib Pegol

Importance:
Page Updated: September 21, 2026
IR Disclosure Date: June 29, 2026
Other

Ribomic Inc.

Company overview · Stock price · Financial data · All IR

View company page →